SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-17-008909
Filing Date
2017-08-10
Accepted
2017-08-10 17:24:28
Documents
26
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 177393
2 ex31-1.htm EX-31.1 11592
3 ex32-1.htm EX-32.1 5169
  Complete submission text file 0001493152-17-008909.txt   608104

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE lcom-20170630.xml EX-101.INS 28794
5 XBRL SCHEMA FILE lcom-20170630.xsd EX-101.SCH 8220
6 XBRL CALCULATION FILE lcom-20170630_cal.xml EX-101.CAL 16085
7 XBRL DEFINITION FILE lcom-20170630_def.xml EX-101.DEF 14072
8 XBRL LABEL FILE lcom-20170630_lab.xml EX-101.LAB 57332
9 XBRL PRESENTATION FILE lcom-20170630_pre.xml EX-101.PRE 45312
Mailing Address 11767 KATY FREEWAY, SUITE 830 HOUSTON TX 77079
Business Address 11767 KATY FREEWAY, SUITE 830 HOUSTON TX 77079 (281) 668-2666
Luckycom Pharmaceuticals Inc. (Filer) CIK: 0001567098 (see all company filings)

IRS No.: 461660653 | State of Incorp.: NV | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 333-187874 | Film No.: 171022353
SIC: 2834 Pharmaceutical Preparations